Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
2022-03-10 08:52
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress
2022-03-10 08:30
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting
2022-03-10 07:00
Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis
2022-03-10 00:57
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
2022-03-09 21:57
NCCN Expands Resources for Treating Rare Cancer Types
2022-03-09 21:56
Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting
2022-03-09 20:00
Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma
2022-03-09 19:08
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
2022-03-09 07:47
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
2022-03-09 06:58
FIRST SURGERIES COMPLETED WITH PATIENT-SPECIFIC 3D PRINTED IMPLANTS PRODUCED AT THE LIMACORPORATE PROMADE POINT OF CARE CENTER AT HOSPITAL FOR SPECIAL SURGERY
2022-03-09 06:16
Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space
2022-03-09 06:10
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
2022-03-09 05:30
Artilux Demonstrates New Breakthrough for Multi Spectral Optical Sensing
2022-03-08 20:56
Femtech after COVID-19: How to Break the Bias and Meet Women's Untapped Healthcare Needs in 2022
2022-03-08 17:02
SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark
2022-03-08 15:31
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies
2022-03-08 08:00
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases
2022-03-08 08:00
Singleron Acquires Proteona
2022-03-07 23:00
Alterity Therapeutics to Present at the 34th Annual Roth Conference
2022-03-07 20:59
1
188
189
190
191
192
452